Literature DB >> 10322829

[Clinical observation on treatment of infantile cholestatic hepatitis syndrome by rhubarb].

Z H Huang1, Y S Dong, W Y Ye.   

Abstract

OBJECTIVE: To evaluate the role of Rhubarb in treating infantile cholestatic hepatitis syndrome (IHS).
METHODS: Forty-four patients of the treatment group were treated with Rhubarb per os and/or duodenal infusion, 20 cases of the control group were treated with general liver protecting therapy such as inosine, vitamin C and glucose. Serum bilirubin, alanine transaminase (ALT) and gamma-glutamyl transferase (gamma-GT) level, bilirubin in duodenal juice and liver size were observed before and after treatment.
RESULTS: In the treatment group, 18 cases were markedly effective, 21 effective, 3 ineffective and 2 were deteriorated, while in the control group, the respective number were 0, 4, 13 and 3.
CONCLUSIONS: Rhubarb was a markedly effective in cholagoging and abating of jaundice, it could promote the recovery of liver function, dredge the cholestasis in cholangiole and micro-cholangiole so as to promote the bile secretion.

Entities:  

Mesh:

Year:  1997        PMID: 10322829

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury.

Authors:  Jia-bo Wang; Hai-ping Zhao; Yan-ling Zhao; Cheng Jin; Dao-jian Liu; Wei-jun Kong; Fang Fang; Lin Zhang; Hong-juan Wang; Xiao-he Xiao
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

2.  Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis.

Authors:  Cong-En Zhang; Ming Niu; Rui-Yu Li; Wu-Wen Feng; Xiao Ma; Qin Dong; Zhi-Jie Ma; Guang-Quan Li; Ya-Kun Meng; Ya Wang; Ping Yin; Lan-Zhi He; Yu-Meng Li; Peng Tan; Yan-Ling Zhao; Jia-Bo Wang; Xiao-Ping Dong; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.